ViGeneron and Daiichi Sankyo have agreed a follow-on collaboration to evaluate vgAAVs as vectors for Daiichi Sankyo novel treatment of prevalent eye diseases.
Analysts from Markets & Markets today released the report "Single use Bioprocessing Market by Product.
Novel foods derived from cell culture instead of animals reduce the environmental impact of diets, water and land use by 80%, report Finnish researchers.
The approval of Valneva’s Corona vaccine is delaying. The European Medicines Agencys CHMP requested additional data.
Organ-on-chip disease model specialist Mimentas BV participates in a €325m funding to accelerate preclinical cancer R&D in the Netherlands.
The US Food & Drug Administration has given the green light for Phase III testing of Hansa Biopharmas imlifidase in anti-GBM disease.
GlaxoSmithKline acquires California-based Sierra Oncology and a ready-for-approval product candidate for myelofibrosis.
A 3D tumour model developed by scientists enables drug screening in metastases
Following phantastic AFM13 data at AACR, Affimed N.V. prices it public offering at $84.4m.
Swiss neurology specialist GeNeuro SA present first data linking silent COVID-19-induced inflammations to neuropsyciatric diseases.